ICUI · Insider Trading

ICU Medical Inc

Every open-market purchase and sale reported by ICUI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
2
code P
Sales
14
code S
Reporting Insiders
12
current holders
ICUI — Recent Form 4 Transactions (latest 2026-09-03)
FiledInsiderRole TypeSharesValue
2026-09-03 Virginia Ruth Sanzone VP, General Counsel Sell −4,856 −$819.15K
2026-09-01 Brian Michael Bonnell Chief Financial Officer Sell −6,381 −$1.12M
2026-08-31 Brian Michael Bonnell Chief Financial Officer Sell −9,307 −$1.61M
2026-08-13 Daniel Woolson VP, GM-Infusion Capital Sell −5,417 −$982.26K
2026-08-12 Ben Sousa Chief Information Officer Sell −2,250 −$401.21K
2026-08-11 Elisha W Finney Director Sell −378 −$68.98K
2026-08-11 Christian B. Voigtlander Chief Operating Officer Sell −8,929 −$1.63M
2026-05-22 Daniel Woolson President Sell −2,123 −$280.68K
2026-05-15 Virginia Ruth Sanzone VP, General Counsel Sell −2,447 −$303.62K
2026-05-13 Elisha W Finney Director M +1,254 —
2026-05-13 Laurie Hernandez Director M +1,254 —
2026-05-13 Kolleen T Kennedy Director M +1,254 —
2026-05-13 Donald Abbey Director M +1,254 —
2026-05-13 David C. Greenberg Director MIXED +1,254 −$52.96K
2026-05-13 David F Hoffmeister Director M +1,254 —
2026-03-26 Donald Abbey Director J −704 —
2026-03-16 Virginia Ruth Sanzone VP, General Counsel MIXED +3,277 −$509.31K
2026-03-16 Daniel Woolson VP, GM-Infusion Capital MIXED +1,629 −$162.98K
2026-03-16 Brian Michael Bonnell Chief Financial Officer MIXED +7,053 −$955.83K
2026-03-16 Vivek Jain Chairman and CEO MIXED +9,827 −$1.53M
2026-03-16 Christian B. Voigtlander Chief Operating Officer MIXED +6,552 −$1.02M
2026-03-16 Ben Sousa Chief Information Officer MIXED +582 −$90.36K
2026-03-09 Vivek Jain Chairman and CEO MIXED +50,498 −$7.85M
2026-03-09 Brian Michael Bonnell Chief Financial Officer MIXED +34,349 −$5.24M
2026-03-09 Daniel Woolson VP, GM-Infusion Capital MIXED +11,676 −$1.08M
2026-03-09 Christian B. Voigtlander Chief Operating Officer MIXED +33,666 −$5.49M
2026-03-09 Virginia Ruth Sanzone VP, General Counsel MIXED +13,174 −$2.15M
2026-03-09 Ben Sousa Chief Information Officer MIXED +4,265 −$696.70K
2025-11-25 Daniel Woolson VP, GM-Infusion Capital Sell −2,897 −$441.36K
2025-11-12 Virginia Ruth Sanzone VP, General Counsel Sell −930 −$132.38K
2025-11-12 Elisha W Finney Director MIXED — −$47.11K
2025-09-15 Vivek Jain Chairman and CEO G — —
2025-08-27 David C. Greenberg Director Buy +1,200 +$151.70K
2025-08-14 Vivek Jain Chairman and CEO Buy +21,929 +$2.47M
2025-05-30 Virginia Ruth Sanzone VP, General Counsel Sell −700 −$93.54K
2025-05-28 Christian B. Voigtlander Chief Operating Officer MIXED +1,185 −$212.11K
2025-05-23 Christian B. Voigtlander Chief Operating Officer MIXED +1,192 −$213.72K
2025-05-21 Christian B. Voigtlander Chief Operating Officer MIXED +1,322 −$246.06K
2025-05-20 Elisha W Finney Director Sell −600 −$83.35K
2025-05-19 Christian B. Voigtlander Chief Operating Officer MIXED — −$468.53K
2025-05-15 Ben Sousa Chief Information Officer Sell −2,000 −$274.71K
2025-05-15 Christian B. Voigtlander Chief Operating Officer MIXED — −$447.42K
2025-05-14 Elisha W Finney Director M +1,723 —
2025-05-13 David F Hoffmeister Director M +1,723 —
2025-05-13 Laurie Hernandez Director M +1,723 —
2025-05-13 Donald Abbey Director M +1,723 —
2025-05-13 David C. Greenberg Director MIXED +1,723 −$95.12K
2025-05-13 Kolleen T Kennedy Director M +1,723 —
2025-03-17 Brian Michael Bonnell Chief Financial Officer M +3,248 —
2025-03-17 Virginia Ruth Sanzone VP, General Counsel MIXED +726 −$128.82K
ICUI — Current Insider Holders
InsiderRole Shares HeldValue
Vivek Jain Chairman and CEO 281,865 $45.94M
Brian Michael Bonnell Chief Financial Officer 56,062 $9.14M
Christian B. Voigtlander Chief Operating Officer 37,377 $6.09M
Daniel Woolson VP, GM-Infusion Capital 17,062 $2.78M
Virginia Ruth Sanzone VP, General Counsel 16,020 $2.61M
David C. Greenberg Director 8,460 $1.38M
David F Hoffmeister Director 6,004 $978.59K
Donald Abbey Director 6,004 $978.59K
Elisha W Finney Director 4,871 $793.92K
Laurie Hernandez Director 4,862 $792.46K
Kolleen T Kennedy Director 4,539 $739.81K
Ben Sousa Chief Information Officer 3,076 $501.36K
ICUI Insider Trading FAQ
Who are the insiders at ICUI?
12 officers, directors and 10%+ beneficial owners currently report holdings in ICUI via SEC Form 4.
Are ICUI insiders buying or selling?
Across the 50 most recent Form 4 filings for ICUI, 2 were open-market purchases (code P) and 14 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is ICUI insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent ICUI filing is dated 2026-09-03.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the ICUI quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.